Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the international autoimmune hepatitis group

Internal Medicine

Volumn 39, Issue 12, 2000, Pages 1008-1012

  Omagari, Katsuhisa ^a   Masuda, Jun Ichi ^a   Kato, Yuji ^a   Nakata, Keisuke ^a   Kanematsu, Takashi ^a   Kusumoto, Yukio ^b   Mori, Iwao ^b   Furukawa, Ryuji ^c   Tanioka, Hajime ^d   Tajima, Heiichiro ^e   Koga, Michiaki ^f   Yano, Michitami ^f   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nagasaki City Hospital   (Japan)

^c Japanese Red Cross Nagasaki Atomic Bomb Hospital   (Japan)

^d Sasebo Shiritsu Sogo Hospital   (Japan)

^e Nagasaki Rousai Hospital   (Japan)

^f Nagasaki Chuo National Hospital   (Japan)

Author keywords

Autoimmune hepatitis; Revised international AIH scoring system

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; HLA DR ANTIGEN;

ADULT; AGED; ALCOHOL LIVER DISEASE; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; BILE DUCT; BLOOD; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; DRINKING BEHAVIOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; JAPAN; LIVER MITOCHONDRION; MALE; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; REVIEW; VALIDATION STUDY; VIRUS HEPATITIS;

ADULT; AGED; ALANINE TRANSAMINASE; ALCOHOL DRINKING; ALKALINE PHOSPHATASE; ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; ASPARTATE AMINOTRANSFERASES; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BILE DUCTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS, AUTOIMMUNE; HEPATITIS, VIRAL, HUMAN; HLA-DR ANTIGENS; HUMANS; JAPAN; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; MITOCHONDRIA, LIVER; RETROSPECTIVE STUDIES;

EID: 0034571360     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.1008     Document Type: Article

References (12)

1. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 18: 998-1005, 1993.
2. Omagari K, Kinoshita H, Kato Y, et al. Clinical features of 89 patients with autoimmune hepatitis in Nagasaki Prefecture, Japan. J Gastroenterol 34: 221-226, 1999.
3. International Autoimmune Hepatitis Group Report. Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: 929-938, 1999.
4. Toda G, Zeniya M, Watanabe F, et al. Present status of autoimmune hepatitis in Japan - Correlating the characteristics with international criteria in an area with a high rate of HCV infection. J Hepatol 26: 1207-1212, 1997.
5. Gordon SC. Diagnostic criteria, clinical manifestations and natural history of autoimmune hepatitis. in: Autoimmune Liver Diseases. 2nd ed. Krawitt EL, Wiesner RH, Nishioka M, Eds. Elsevier, Amsterdam, 1998: 343-360.
6. Toda G. Interferon or corticosteroid: Treatment of patients with chronic hepatitis C positive for serum markers of autoimmune diseases. Intern Med 36: 233-235, 1997.
7. Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med 125: 588-598, 1996.
8. Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 28: 360-365, 1998.
9. McNair ANB, Moloney M, Portmann BC, Williams R, McFarlane IG. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases. Am J Gastroenterol 93: 777-784, 1998.
10. Mackay IR. Autoimmune disease overlaps and the liver: Two for the price of one? J Gastroenterol Hepatol 15: 3-8, 2000.
11. McFarlane IG. The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis. Gut 42: 599-602, 1998.
12. Mackay IR, Davies JM, Rowley MJ. Towards the pathogenesis of autoimmune liver disease. J Autoimmun 13: 163-169, 1999.